1.
Evaluation of Natural killer activated receptor NKG2D, Inhibitory receptor KIR2DL1 and soluble ligand MICA in Iraqi patients of Acute myeloid leukemia. Journal of Pharmaceutical Negative Results. 2022;13:148-155. doi:10.47750/pnr.2022.13.S05.21